More PRNewswire
View Older Stories View Newer Stories-
CREATE Medicines Doses First Patient in Frontline HCC Trial Evaluating MT-303, an In Vivo CAR Therapy, in Combination with Standard-of-Care Immunotherapy
-
Indigo Insurance Selects Duck Creek OnDemand to Accelerate Modernization and Support Rapid Growth
-
Verismo Therapeutics Shares Positive Preclinical Data at ASH 2025 Comparing SynKIR™-310 With Conventional CAR-T
-
ZE Government Solutions Products Available for Immediate Purchase Through immixGroup GSA Schedule Contract
-
San Diego County modernizes budgeting with cloud-based CGI Advantage®
-
Education Management Solutions Continues Leadership Role as Presidential Sponsor of IMSH 2026 for Sixth Consecutive Year
-
Trinity Gas Storage Reaches Final Investment Decision on Phase II Expansion
-
The Canton Network's Industry Working Group Demonstrates Next Phase of Onchain U.S. Treasury Financing on Canton Network
-
Invesco Ltd. Announces November 30, 2025 Assets Under Management
-
Clarins launches its mobile app to elevate its customer relationship, in partnership with Merkle
-
Qvinci's Newest Patent Revolutionizes Automated, Disparate-Data Processing and Business Intelligence for Multi-Location Organizations
-
Dove Brings Message of Body Confidence Back to Football's Biggest Night
-
Curis Provides Updated Data from its Frontline AML Triplet Study
-
TrojAI Launches Free AI Red Team Report Card to Help Organizations Identify and Mitigate AI Risks
-
Jensen Hughes Announces Acquisition of Safety Management Services, Inc.
-
Allmed Solutions Achieves Landmark 'Needle-Stick' Heart Valve Replacement
-
GNW Consulting Closes Breakout Year, Doubling Team and Debuting Enterprise AI Readiness Offering
-
Land O'Lakes and Food Network Champion MacKenzie Smith Share Elevated, Effortless Holiday Hosting Tips for a More Welcoming and Connected Celebration
-
Findhelp and AIDA Healthcare Announce Integration Partnership to Transform Post‑Acute Care Referrals
-
CompuCycle Becomes Exclusive Woman-Owned Texas E-Waste Processor with ISO 27001 Data Security Certification
-
Lee's Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights
-
Panduit Sets a New Benchmark in Cable Cleat Testing
-
Purina Announces Donations to Five Leading Veterinary Schools to Foster Advancements in Veterinary Care
-
THE LEELA UNVEILS MIRRORS OF HOPE: LIPPAN ART CHRISTMAS TREES CRAFTED BY WOMEN ARTISANS
-
Antero Midstream Announces Launch of $500 Million Offering of Senior Notes
-
Spectral Capital Announces Projected $450,000,000 in Projected 2026 Revenue in Connection with NASDAQ Uplisting; Engages Revere Securities
-
US Air Force Awards ThroughPut.ai Phase III Contract for "Aircraft Availability Optimization"
-
From Research to Measurable Patient Outcomes, Bio-IT World Conference & Expo Celebrates 25th Annual Event Advancing the Future of Precision Medicine
-
Lunai Bioworks Identifies Three Parkinson's Subtypes and Prioritized Drug Targets to Accelerate Proof-of-Concept Programs and Strategic Partnerships in a $13B Market
-
Ajust Design Adds Strategic Communication Practice as Private Equity Firms Encounter Growing Competition for Capital
-
Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI® plus DARZALEX FASPRO® as a potential standard of care as early as second line for patients with relapsed/refractory multiple
-
Elanco Investor Day Defines New Era as Sustainable Growth Company
-
MassMedia Accelerates Paid Media Capabilities With Leadership Appointment of Kristen Carter
-
From a Simple Idea to a Global Standard: EV Blocks Founder Wins Global Entrepreneur of the Year 2025
-
Recordati Rare Diseases Announces Real-World Data on Long-Term Safety of ENJAYMO® (sutimlimab-jome) in Cold Agglutinin Disease and Cold Agglutinin Syndrome (CAD/CAS) at American Society of Hematology
-
Lilly's Jaypirca (pirtobrutinib) significantly improved progression-free survival, reducing the risk of progression or death by 80%, versus chemoimmunotherapy in patients with treatment-naïve CLL/SLL
-
Pirtobrutinib Outperforms Bendamustine Plus Rituximab for Previously Untreated CLL/SLL
-
Tec-Dara Combination Offers Substantial Improvement Over Standard Second-Line Therapies for Relapsed or Refractory Multiple Myeloma
-
Novel Agent Ianalumab Added to Standard Therapy Extends Time to Treatment Failure in Patients with Previously Treated Immune Thrombocytopenia
-
Drug Reduced Need for Blood Transfusions During Hospitalization for Non-Cardiac Surgery
-
Pariveda Named a 2025 Geo and Global AWS Partner Award Finalist
-
Pariveda Awarded a 2025 AWS Partner Award
-
Bed Bath & Beyond Appoints Nora Gomez as Chief Merchandising Officer
-
Safebooks AI Raises $15 Million to Automate Revenue Data Integrity for Enterprise Finance Teams
-
SYMERA Launches WESUITE a Consumer Engagement Platform that combines Web3 and Gamification with Behavioural Science, Powered by Hedera
-
CAGC Partners with NCDMV to Make Highway Work Zones Safer
-
USLege Achieves SOC 2 Type II Compliance and TX-RAMP Level 2 Certification
-
MatrixSpace Launches Portable 360 Radar™ for Rapid, Resilient Counter-Drone Operations Anywhere
-
University of Saskatchewan Selects QuickLogic eFPGA HardIP for StarRISC MCU
-
Rush University's Former Chair of Pain Medicine, Dr. Timothy Lubenow, Joins MAPS Centers for Pain Control to Expand Access to Advanced Pain Care in Chicago
